Enoxaparin Sodium

CAS 679809-58-6 14 current records 1 historicalBiologic

Who holds supplier records for Enoxaparin Sodium? 14 organisations hold a current record for Enoxaparin Sodium: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (7) and India (4); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Enoxaparin Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/enoxaparin-sodium

Reading the evidence

  • 14 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in China

    7 of the 11 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.

  • 8 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (14)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Enoxaparin Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.

China7India4Country not recorded for 3
Need Enoxaparin Sodium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Enoxaparin Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 3 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
GLAND PHARMA LIMITED HyderabadIN
CEP 2003-266 - Rev 04
Enoxaparin sodium
Nov 2024Inspected Oct 2025
Germany
Dongying Tiandong Pharmaceutical Co., Ltd. Dongying CityCN
R1-CEP 2005-258 - Rev 05
Enoxaparin sodium
Jul 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Enoxaparin Sodium are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • Italy · Inactive DMF 16748 · filed Aug 2003

Overview

Enoxaparin Sodium is a low molecular weight heparin used as an anticoagulant to prevent and treat deep vein thrombosis or pulmonary embolism. It works as an antithrombotic by inhibiting factor Xa and IIa, thus preventing clot formation.

Chemical identity

IUPAC name
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
Canonical SMILES
CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O
InChIKey
HTTJABKRGRZYRN-UHFFFAOYSA-N
Synonyms
Innohep API, clexane, enoxaparin sodium salt, klexane, lovenox, pk 10169, pk-10169, rp 54563, rp-54563

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Low Molecular Weight Heparin
Chemical structure
Low-Molecular-Weight

Therapeutic areas

CardiovascularThrombosisHemostasis

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Enoxaparin Sodium?

14 organisations hold an active US FDA Type II Drug Master File or a CEP for Enoxaparin Sodium: Shenzhen Techdow Pharmaceutical Co., Ltd. (China), Dongying Tiandong Pharmaceutical Co.,Ltd (China), APITORIA PHARMA PRIVATE LTD (India), CELSUS LABORATORIES INC, DEFT ORGANICS LIMITED (India), Emcure Pharmaceuticals Limited (India), HANGZHOU JIUYUAN GENE ENGINEERING CO LTD (China) and HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD (China), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Enoxaparin Sodium Drug Master Files are active?

Shenzhen Techdow Pharmaceutical Co., Ltd. (DMF 32744, 26891), Dongying Tiandong Pharmaceutical Co.,Ltd (DMF 18452), APITORIA PHARMA PRIVATE LTD (DMF 41327), CELSUS LABORATORIES INC (DMF 21798), DEFT ORGANICS LIMITED (DMF 41625), Emcure Pharmaceuticals Limited (DMF 26947), HANGZHOU JIUYUAN GENE ENGINEERING CO LTD (DMF 25242) and HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD (DMF 26258) and 5 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Enoxaparin Sodium records mean?

1 organisation has only inactive Type II DMFs for Enoxaparin Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Enoxaparin Sodium have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Enoxaparin Sodium on the EDQM register, including GLAND PHARMA LIMITED Hyderabad (IN) and Dongying Tiandong Pharmaceutical Co., Ltd. Dongying City (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Enoxaparin Sodium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Enoxaparin Sodium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.